Trump admin concludes Medicare drug subsidy
The Centers for Medicare & Medicaid Services announced the end of a temporary subsidy program that helped lower Medicare Part D prescription drug premiums, which began in 2024. The program's elimination is expected to cause modest premium increases for millions of Medicare beneficiaries in 2027, though some may see lower costs. Officials state the decision will prevent billions in taxpayer spending and maintain access to low-cost plans, amid ongoing efforts to lower drug prices through negotiations.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading